Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.
about
RNA dimerization defect in a Rous sarcoma virus matrix mutant.Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cellsAlterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag proteinAn assembly domain of the Rous sarcoma virus Gag protein required late in buddingTy3 capsid mutations reveal early and late functions of the amino-terminal domainFine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domainViral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus.A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral buddingLate domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimerasConditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding.In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.Identification of retroviral late domains as determinants of particle size.U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.Genetic determinants of Rous sarcoma virus particle size.Type D retrovirus capsid assembly and release are active events requiring ATP.Particle size determinants in the human immunodeficiency virus type 1 Gag proteinAnalysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescueThe C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domainThe gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactionsMembrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA.Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae.Virus maturation by budding.p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing proteaseSelf-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.In vivo interference of Rous sarcoma virus budding by cis expression of a WW domainThe role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicingA long terminal repeat-containing retrotransposon of Schizosaccharomyces pombe expresses a Gag-like protein that assembles into virus-like particles which mediate reverse transcription.Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release.Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein.
P2860
Q24524289-7E4C099B-2498-401E-8946-376A3EAE76ACQ24555190-2DD37CCA-7A09-4061-B675-ACAEC1CD74FDQ24609231-5A934AE1-009A-4BAB-92B3-137977632C49Q24645654-BE20ADA9-257D-4437-B82B-06666CB2F8A2Q27931343-D4E1AF82-350B-412B-BF8B-EF740191737FQ30176873-DDE1F297-4D7D-4C43-8A64-52FDD831AB1BQ30327614-61677583-B386-4459-A3D3-A6A26685E6D7Q30452638-84912AAA-2B50-4594-8FFE-6A6EF17BEF2FQ33643776-13D1A332-839D-444A-9ADB-3B08E90A05F1Q33645178-4401F64E-C041-4A2A-AA5E-C8B476C7208BQ33653116-0068B829-F08D-49EF-A9F6-5A92F5B5AF2CQ33653475-36B7E334-F501-485D-BFF0-881E5BCD5144Q33653548-D2232479-3594-4858-85E3-4C09B2295D36Q33653701-E240504F-EE22-4121-970C-AA2BCDBDB484Q33780632-7026D38F-E87F-4C8E-AE71-305ABBDC0AC9Q33782075-5556A786-09AD-4EC1-82AE-F3A6C04DA99FQ33783128-78B6D96B-9A90-4E04-AD0C-E6D624B19C6AQ33783955-2B5A16A6-A831-4072-A2F5-72CEBB2C8AAFQ33784754-6FF20796-559E-402C-960B-F006567E137CQ33785351-A837261D-8F6F-4980-8D8A-77B28F589E90Q33785479-69EFFA0B-6A94-48BE-B5B2-B2D91EE770D8Q33801779-2D38CB13-B467-4B0D-A2BA-03333D889E7AQ33816490-3EDFEF04-D655-4EEC-AF7E-73AC2D000D96Q33843462-A9198517-CAAF-4E89-ACBC-19C4F05CED91Q33844210-96271B78-4B9B-4D17-A87B-C08DD285ECF2Q33874447-8D48D987-30E1-4300-92E3-152ABD31EA03Q33900316-CFB9B85C-6B6F-49FB-A72A-68749E62BEB0Q33927343-71DD428A-6819-472A-A06B-2C9D250A0021Q34021302-D6E6765B-DE59-4A59-AF1A-56B0282D6541Q34030593-73F0272E-95C3-41C1-9891-DBCFCD85C307Q34068037-E1B4C1DC-434C-4901-BFD1-FEDCD49E433FQ34288376-206E0EB6-6DB5-4477-9F14-3EC4DB317F76Q34304675-133F3DDB-9468-4FF1-B398-2C8392C2C175Q34332213-3C85837F-5ACB-45E5-AD24-7EB7489555C7Q34361775-B3A41CA1-71B6-4DF5-941B-DB92C92578B3Q34975957-84AE94FB-5CC5-4BF6-8DDF-6F17AF624B73Q35542714-BDAFCB81-0E6A-48F1-A42B-1F2D9D394A63Q35830898-9BCFE00B-51CC-425F-9773-3E42C73AC733Q35837753-308C8E7F-E8C3-46F0-8261-67E34A802B8BQ35841323-E393C74E-0730-48B1-B949-4C71ABCBB9EB
P2860
Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Characterization of a small (2 ...... ompetent for particle release.
@en
type
label
Characterization of a small (2 ...... ompetent for particle release.
@en
prefLabel
Characterization of a small (2 ...... ompetent for particle release.
@en
P2860
P1433
P1476
Characterization of a small (2 ...... ompetent for particle release.
@en
P2093
P2860
P304
P407
P577
1993-09-01T00:00:00Z